Hypothesis Comparison

⚛ Collide these ⚔ Judge as Duel

Comparing 2 hypotheses side-by-side

|

Activity-dependent MAP6 scaffolding at synapses

MAP6 · neurodegeneration · -
Composite
0.600
Price
$0.51
Evidence For
0
Evidence Against
0

MAP6 may scaffold signaling complexes at synapses in an activity-dependent manner, linking NMDA receptor activation to cytoskeletal remodeling via its multiple functional domains Prediction: MAP6 will physically associate with synaptic signaling proteins in a phosphorylation-dependent manner, and LTP-inducing stimulation will recruit MAP6 to dendritic spines

Tau/MAP6 antagonism in neurodegeneration progression

MAP6 · neurodegeneration · -
Composite
0.650
Price
$0.51
Evidence For
0
Evidence Against
0

In tauopathies, pathological tau alterations may disrupt the antagonistic balance with MAP6, causing excessive stabilization and loss of adaptive plasticity, while in other conditions the relationship may be shifted toward excess lability Prediction: MAP6 expression levels or post-translational modifications will be altered in tauopathy patient samples as a compensatory response to tau dysfunction

Convergent vs Divergent Predictions

This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.

MAP6Unspecified Mechanismneurodegeneration
Convergent signals
  • MAP6 recurs across 2 selected hypotheses with aligned directionality in unspecified mechanism.
Divergent signals
  • No direct polarity conflicts detected among the selected hypotheses.

Verdict Summary

1/11
dimensions won
Activity-dependent MAP6 scaffolding at s
6/11
dimensions won
Tau/MAP6 antagonism in neurodegeneration

Radar Chart — 10 Dimensions

Score Comparison Bars

Mechanistic
0.65
0.70
Evidence
0.60
0.65
Novelty
0.60
0.65
Feasibility
0.60
0.65
Impact
0.00
0.00
Druggability
0.00
0.00
Safety
0.00
0.00
Competition
0.00
0.00
Data
0.00
0.00
Reproducible
0.76
0.81
KG Connect
0.50
0.50

Score Breakdown

DimensionActivity-dependent MAP6 scaffoTau/MAP6 antagonism in neurode
Mechanistic0.6500.700
Evidence0.6000.650
Novelty0.6000.650
Feasibility0.6000.650
Impact0.0000.000
Druggability0.0000.000
Safety0.0000.000
Competition0.0000.000
Data0.0000.000
Reproducible0.7570.815
KG Connect0.5000.500

Evidence

Activity-dependent MAP6 scaffolding at synapses

No evidence citations yet

Tau/MAP6 antagonism in neurodegeneration progression

No evidence citations yet

Price History Overlay